) This project studies the potential improvements allowed in clinical treatment planning through the use of a more sophisticated and generalized automated plan optimization process. The overall goal of this project is to demonstrate and then evaluate the improvements and changes which result from improved sophistication of the automated optimization process, with the intended aim of enhancing the physician's ability to make improved, more quantitative decisions trading off normal tissue dose, tumor dose, complexity, and many other issues. This project will determine whether this enhanced optimization capability will allow the physician to create optimized plans which will achieve the desired clinical goals and be reliably delivered with assurance that the patient's actual resulting dose distributions will closely match the design. The project will demonstrate and evaluate the potential benefits of plan optimization which 1) accounts for a number of clinical realities such as geometrical uncertainties and treatment delivery time limitations, 2) makes use of more sophisticated cost functions, 3) utilizes multistep or multilayer optimization strategies, and 4) incorporates all available enhancements to investigate the utility of dynamic refinement, which involves re-optimization of the patient's treatment plan(s) taking into account issues which arise throughout the time of the patient's treatment course. This project will utilize developments and information obtained by the other projects, including delivery and dosimetric constraints and issues from Project 2, patient setup and organ motion uncertainties issues and algorithms from Project 3, and clinical protocols, data, plans, and plan evaluations involved in the clinical protocols and treatments performed by Project 4. The capabilities and evaluations obtained through the course of this work will also be available for the optimization-related studies in Projects 2 and 3, and will be used in the development of improved clinical treatment plans and treatment planning and optimization protocols for use in the Project 4 clinical studies. The improvements developed, studied and evaluated by this project should lead to much more clinically relevant plan optimization, making possible improved and more successful patient treatments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA059827-07
Application #
6503475
Study Section
Project Start
2001-09-24
Project End
2002-07-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Wang, Shulian; Campbell, Jeff; Stenmark, Matthew H et al. (2018) A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer. Radiother Oncol 126:506-510
Sapir, Eli; Tao, Yebin; Schipper, Matthew J et al. (2018) Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:122-130
Hawkins, Peter G; Boonstra, Philip S; Hobson, Stephen T et al. (2018) Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Transl Oncol 11:102-108
Sun, Yilun; Hawkins, Peter G; Bi, Nan et al. (2018) Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 100:107-114
Kong, Feng-Ming Spring; Li, Ling; Wang, Weili et al. (2018) Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol :
Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela et al. (2018) Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol 41:326-331
Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal et al. (2018) Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 100:950-958
Miften, Moyed; Vinogradskiy, Yevgeniy; Moiseenko, Vitali et al. (2018) Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys :
Konerman, Matthew C; Lazarus, John J; Weinberg, Richard L et al. (2018) Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation. Circ Heart Fail 11:e004473
Tseng, Huan-Hsin; Wei, Lise; Cui, Sunan et al. (2018) Machine Learning and Imaging Informatics in Oncology. Oncology :1-19

Showing the most recent 10 out of 289 publications